These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2507120)

  • 1. Alloantibodies other than anti-D in pregnant women.
    Chow MP; Yung CH; Hu HY; Lyou JY; Hwan MY; Shi YJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Mar; 43(3):205-7. PubMed ID: 2507120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the newborn due to rare alloantibodies.
    Zuliani G; Moroni GA; Buscaglia M; Morotti R; Pardi G
    Ric Clin Lab; 1983; 13(4):449-57. PubMed ID: 6419339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous drug use is associated with alloimmunization in pregnancy.
    Lappen JR; Stark S; Gibson KS; Prasad M; Bailit JL
    Am J Obstet Gynecol; 2016 Sep; 215(3):344.e1-6. PubMed ID: 26996989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigation of Rh antibodies in pregnant women.
    Lajos J
    Haematologia (Budap); 1982; 15(3):315-21. PubMed ID: 6821044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn in monozygotic twins caused by anti-c alloantibodies of the rhesus system].
    Gligorović VN; Gligorović S
    Bilt Hematol Transfuz; 1980; 8(1):83-9. PubMed ID: 6802130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme-linked immunosorbent assay for the quantitation of IgG anti-D and IgG subclasses in the sera of alloimmunized patients.
    Lambin P; Ahaded A; Debbia M; Lauroua P; Rouger P
    Transfusion; 1998 Mar; 38(3):252-61. PubMed ID: 9563405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme.
    Foudoulaki-Paparizos L; Valsami S; Bournas N; Tsantes A; Grapsas P; Mantzios G; Travlou A; Politou M
    Transfus Med; 2013 Aug; 23(4):254-9. PubMed ID: 23826966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and analysis of anti-Rh blood group antibodies].
    Wu YJ; Wu Y; Chen BC; Liu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):604-6. PubMed ID: 18538092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cases of irregular blood group antibodies other than anti-D in pregnancy. Frequency and clinical significance.
    Kornstad L
    Acta Obstet Gynecol Scand; 1983; 62(5):431-6. PubMed ID: 6421084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclasses of anti-Rh antibodies in pregnant women.
    Frankowska K; Górska B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1095-100. PubMed ID: 107909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microtitration of anti-RH1 antibodies: interest in the follow-up of pregnant women].
    Dupont M; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfus Clin Biol; 2007 Oct; 14(4):381-5. PubMed ID: 18037318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual occurrence of six anti-erythrocyte alloantibodies in an Rh(D)-negative man with myelodysplastic syndrome.
    Wakui H; Tada I; Kimura Y; Yoshida K; Endo Y; Miura AB
    Jpn J Med; 1989; 28(6):736-9. PubMed ID: 2517443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.